Business Segments AstraZeneca PLC

Equities

Market Closed - London S.E. Other stock markets 16:35:29 18/09/2024 BST			5-day change	1st Jan Change
11,856.00 ^GBX	-0.94%		-4.43%	+11.85%

06:13pm	European Equities Close Lower in Wednesday Trading; EU, Euro Area Inflation Declines in August	MT
01:43pm	AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment	MT

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment

Fiscal Period: December	2019	2020	2021	2022	2023
Pharmaceutical Products
Biopharmaceuticals	24.38B	26.62B	37.42B	44.35B	45.81B
Total Assets	61.38B	66.73B	105B	96.48B	101B
Interest Expense	-780M	-738M	-776M	-917M	-1.22B
Income Tax Expense	321M	772M	-380M	-792M	938M
CAPEX	-2.46B	-2.61B	-2.2B	-2.57B	-1.36B
EBT	1.66B	3.94B	-201M	2.51B	6.91B
Gross Profit	19.46B	21.32B	24.98B	31.96B	37.54B
D&A	2.73B	2.83B	4.04B	5.18B	4.85B
Operating Income	2.92B	5.16B	1.06B	3.76B	8.19B
Net Income	1.34B	3.2B	112M	3.29B	5.96B

Geographical breakdown of sales

Fiscal Period: December	2019	2020	2021	2022	2023
United States	8.05B	8.96B	12.05B	17.28B	18.12B
Total Assets	4.51B	5.5B	6.06B	6.04B	6.11B
CAPEX	-120M	-116M	-94M	-	-
EBT	923M	745M	931M	660M	1.15B
Operating Income	964M	742M	943M	646M	1.15B
China	4.87B	5.34B	6B	5.74B	5.87B
Japan	2.52B	2.57B	3.4B	3.99B	3.64B
United Kingdom	1.82B	1.74B	3.24B	3.12B	3.37B
Total Assets	15.3B	17.85B	16.62B	16.79B	19.62B
CAPEX	-2.26B	-1.61B	-810M	-	-
EBT	93M	518M	-1.48B	272M	-577M
Operating Income	466M	824M	-950M	1.12B	665M
Other Rest of Europe	1.29B	1.39B	1.95B	2.71B	3.11B
Germany	704M	937M	1.49B	1.9B	2.1B
Other Asia, Africa & Australasia	1.42B	1.53B	2.38B	2.41B	2.04B
Sweden	834M	1.03B	2.32B	1.72B	1.7B
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBT	-	-	-	-	-
Operating Income	-	-	-	-	-
Total Assets	18.18B	19.74B	48.38B	40.67B	40.64B
CAPEX	-386M	-505M	-26.53B	-	-
EBT	1.01B	2.36B	2.68B	2.71B	5B
Operating Income	1.5B	2.84B	3B	2.94B	4.88B
Other Americas	814M	761M	1.2B	1.18B	1.68B
France	578M	653M	915M	1.11B	1.15B
Canada	466M	596M	772M	1.17B	967M
Spain	359M	398M	578M	738M	847M
Italy	396M	431M	577M	735M	813M
Australia	266M	282M	547M	571M	390M
Intra-Group Eliminations	-	-	-	-	-
Belgium	-	-	-	-	-
Corporate	-	-	-	-	-
Total Assets	23.38B	23.64B	34.3B	32.99B	34.75B
CAPEX	-236M	-286M	-10.81B	-	-
EBT	-474M	297M	-2.4B	-1.14B	1.33B
Operating Income	-8M	758M	-1.94B	-954M	1.5B